AC IMMUNE SA SF-02 (IMR) — Net Asset Quality Index
AC IMMUNE SA SF-02 (IMR) has a Net Asset Quality Index of 22.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €137.42 Million minus total liabilities of €105.89 Million yields net assets of €31.53 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of AC IMMUNE SA SF-02 to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
AC IMMUNE SA SF-02 Net Asset Quality Index Over Time (2021–2025)
This chart shows how AC IMMUNE SA SF-02's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 22.9%, representing net assets of €31.53 Million against total assets of €137.42 Million EUR. See AC IMMUNE SA SF-02 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for AC IMMUNE SA SF-02 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for AC IMMUNE SA SF-02 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see IMR market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 29.1% | €44.88 Million | €154.25 Million | €109.37 Million | ▼ -19.5 pp |
| 2024 | 48.6% | €112.27 Million | €230.91 Million | €118.64 Million | ▼ -39.3 pp |
| 2023 | 87.9% | €160.64 Million | €182.81 Million | €22.17 Million | ▼ -3.0 pp |
| 2022 | 90.9% | €168.99 Million | €185.94 Million | €16.95 Million | ▲ +2.2 pp |
| 2021 | 88.7% | €231.98 Million | €261.44 Million | €29.46 Million | — |